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Background
Decreased activity of ADA2, caused by recessive muta-
tions in CECR1 gene (Cat Eye Syndrome Chromosome
Region, Candidate 1 also known as ADA2), results in
cutaneous or systemic vasculitis with variable clinical
manifestations.
Case
A patient with juvenile onset recurrent febrile attacks
associated with familial polyarteritis nodosa (PAN) and
who carries CECR1 and MEFVgene mutations is
described. The index case, a 23 year old male patient
with recurrent attacks of fever and arthritis since the age
of 7 was diagnosed initially as Familial Mediterranean
Fever (FMF). A beneficial response to treatment with col-
chicine was observed. A year later he developed livedo
reticularis and nodular dermal lesions compatible with
cutaneous PAN. He was treated with prednisolone and
azathioprine. Arthralgia, fever and dermal lesions
regressed and he was in remission until he developed
anemia and macrocytosis a year later and azathioprine
was stopped. Due to the activation of his skin vasculitis
anakinra 100mg/day was instituted. The beneficial
response obtained with anakinra was lost when he dis-
continued the treatment. A family history revealed a
brother two years older than himself who also had livedo
reticularis, Raynaud’s phenomena, fever and arthritis
since the age of 8, diagnosed as PAN before the index
case and died at age 22 because of gut perforation sec-
ondary to acute mesenteric ischemia. With the probable
diagnosis of ADA2, the index patient was analyzed for
CECR1 gene mutations on chromosome 22q11.1. After
amplification of the exons 2, 4, 5, 6 and 9 on PCR, DNA
sequencing analysis was performed. A homozygous
c.139G-A transition in exon 2, resulting in a gly47-to-arg
(G47R) substitution at a highly conserved residue in the
dimerization domain was identified in this patient who
was known to be heterozygous for M694V and R202Q
mutations of the MEFV gene. His vasculitic lesions
responded to Infliximab after the fourth infusion together
with daily colchicine treatment.
Conclusion
CECR1 gene mutation should be considered in cases pre-
senting especially with early onset PAN. Infliximab
maybe an effective therapy in these cases which are
related with increased mortality. This is the first case that
is reported to carry both CECR1 and MEFV gene muta-
tions presenting with characteristic phenotypes of FMF
and ADA2. The role of CECR1 mutations in the well
documented association of FMF and PAN will be an
interesting field of investigation in near future.
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